North Dakota has joined 28 other states in capping insulin prices for patients at $25 per month. This bipartisan effort aims to alleviate the financial burden on individuals with diabetes, who often face thousands of dollars in out-of-pocket costs for the life-saving medication. The cap limits patient co-pays, providing relief from anxiety and the risk of rationing insulin due to high prices. While prices have seen some moderation due to public backlash, these caps offer a crucial layer of protection. AI
RANK_REASON State-level policy change impacting a significant number of citizens and a critical medication. [lever_c_demoted from significant: ic=1 ai=0.1]
- American Diabetes Association
- Ang Kritzberger
- Democratic Party
- insulin
- Kritzberger
- Nina
- North Dakota
- Republican Party
- Sean Cleary
- type-1 diabetes
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →